ABT
Abbott Laboratories
Price:  
103.95 
USD
Volume:  
4,455,637.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Abbott EV/EBITDA

9.6%
Upside

As of 2024-05-27, the EV/EBITDA ratio of Abbott Laboratories (ABT) is 15.42. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Abbott's latest enterprise value is 189,136.53 mil USD. Abbott's TTM EBITDA according to its financial statements is 12,267.00 mil USD. Dividing these 2 quantities gives us the above Abbott EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 15.0x - 20.5x 16.9x
Forward P/E multiples 18.2x - 23.3x 20.5x
Fair Price 100.62 - 139.92 113.89
Upside -3.2% - 34.6% 9.6%
103.95 USD
Stock Price
113.89 USD
Fair Price

Abbott EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-05-24 15.42
2024-05-23 15.46
2024-05-22 15.54
2024-05-21 15.28
2024-05-20 15.31
2024-05-17 15.44
2024-05-16 15.55
2024-05-15 15.51
2024-05-14 15.43
2024-05-13 15.53
2024-05-10 15.53
2024-05-09 15.52
2024-05-08 15.56
2024-05-07 15.73
2024-05-06 15.66
2024-05-03 15.69
2024-05-02 15.70
2024-05-01 15.75
2024-04-30 15.70
2024-04-29 15.89
2024-04-26 15.93
2024-04-25 15.83
2024-04-24 15.84
2024-04-23 15.93
2024-04-22 15.86
2024-04-19 15.89
2024-04-18 15.61
2024-04-17 15.69
2024-04-16 16.16
2024-04-15 16.12
2024-04-12 16.15
2024-04-11 16.48
2024-04-10 16.44
2024-04-09 16.62
2024-04-08 16.35
2024-04-05 16.45
2024-04-04 16.29
2024-04-03 16.46
2024-04-02 16.56
2024-04-01 16.57
2024-03-28 16.80
2024-03-27 16.77
2024-03-26 16.49
2024-03-25 16.28
2024-03-22 16.36
2024-03-21 16.49
2024-03-20 16.49
2024-03-19 16.72
2024-03-18 16.62
2024-03-15 17.05